ETHICS STATEMENT
The approval for the trial was obtained from the Vilnius Regional Biomedical Research Ethics Committee, Vilnius, Lithuania (Approval No. 158200‐17‐949‐453; September 12th, 2017). The principles of Declaration of Helsinki were followed. All eligible patients were provided with the information about the study and signed an informed consent form on the day of inclusion.